Get the Stockscreener App
2.44
5.97%
-0.155
After Hours:
2.44
Armata Pharmaceuticals Inc stock is traded at $2.44, with a volume of 13,362.
It is down -5.97% in the last 24 hours and up +2.09% over the past month.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections in the United States. The company develops its products using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company is also developing and advancing synthetic phage for treating diseases caused by pseudomonas aeruginosa. Armata Pharmaceuticals, Inc. is headquartered in Marina del Rey, California.
See More
Previous Close:
$2.595
Open:
$2.595
24h Volume:
13,362
Relative Volume:
0.74
Market Cap:
$88.40M
Revenue:
-
Net Income/Loss:
$-41.36M
P/E Ratio:
-1.4878
EPS:
-1.64
Net Cash Flow:
$-42.09M
1W Performance:
-2.79%
1M Performance:
+2.09%
6M Performance:
+17.31%
1Y Performance:
+1.46%
1-Day Range:
$2.44
$2.60
1-Week Range:
$2.43
$2.68
52-Week Range:
$0.8981
$2.96
Armata Pharmaceuticals Inc Stock (ARMP) Company Profile
Name
Armata Pharmaceuticals Inc
Sector
Industry
Phone
310-655-2928
Address
4503 Glencoe Avenue, Marina del Rey, CA
Compare ARMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARMP
Armata Pharmaceuticals Inc
|
2.44 | 94.02M | 0 | -41.36M | -42.09M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Armata Pharmaceuticals Inc Stock (ARMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-19-19 | Initiated | Ladenburg Thalmann | Buy |
Armata Pharmaceuticals Inc Stock (ARMP) Latest News
What’s the recovery path for long term holders of Armata Pharmaceuticals Inc.Market Sentiment Summary & Breakout Confirmation Trade Signals - Newser
Strategies to average down on Armata Pharmaceuticals Inc.2025 Volume Leaders & Free Verified High Yield Trade Plans - Newser
Multi asset correlation models including Armata Pharmaceuticals Inc.Weekly Gains Report & Expert Approved Trade Ideas - Newser
Armata Pharmaceuticals Inc. stock outlook for YEARTrade Entry Report & Reliable Price Action Trade Plans - Newser
What institutional flow reveals about Armata Pharmaceuticals Inc.Market Activity Summary & Daily Technical Stock Forecast Reports - Newser
Is Armata Pharmaceuticals Inc. still worth holding after the dipStock Surge & Expert Curated Trade Setups - Newser
Analyzing net buyer seller activity in Armata Pharmaceuticals Inc.Earnings Summary Report & AI Driven Stock Movement Reports - Newser
Combining price and volume data for Armata Pharmaceuticals Inc.July 2025 Recap & Free Technical Pattern Based Buy Signals - Newser
Is this a good reentry point in Armata Pharmaceuticals Inc.2025 Earnings Impact & Real-Time Volume Surge Alerts - Newser
Is Armata Pharmaceuticals Inc. forming a reversal pattern2025 Technical Patterns & Safe Entry Momentum Stock Tips - Newser
Published on: 2025-08-25 20:58:57 - Newser
Can swing trading help recover from Armata Pharmaceuticals Inc. lossesJuly 2025 News Drivers & High Accuracy Investment Signals - Newser
How to recover losses in Armata Pharmaceuticals Inc. stockPortfolio Performance Report & Stock Market Timing Techniques - Newser
Automated trading signals detected on Armata Pharmaceuticals Inc.Portfolio Growth Summary & High Accuracy Trade Alerts - Newser
Insider Trends: How cyclical is Armata Pharmaceuticals Inc.’s revenue stream2025 Bull vs Bear & Technical Pattern Based Signals - theviewers.co.kr
Is Armata Pharmaceuticals Inc. the Top Chart Pick This WeekJobs Report & Consistent Return Investment Signals - beatles.ru
Armata Pharmaceuticals Secures $15M Loan for Development - MSN
What is Armata Pharmaceuticals Inc.’s valuation compared to sectorDip Buying & Daily Volume Surge Trade Alerts - theviewers.co.kr
Is Armata Pharmaceuticals Inc. impacted by rising rates2025 Winners & Losers & Reliable Breakout Stock Forecasts - sundaytimes.kr
Using economic indicators to assess Armata Pharmaceuticals Inc. potentialAnalyst Upgrade & Smart Allocation Stock Tips - Newser
Is Armata Pharmaceuticals Inc. trending in predictive chart modelsBear Alert & AI Powered Buy/Sell Recommendations - Newser
Combining machine learning predictions for Armata Pharmaceuticals Inc.Oil Prices & Weekly Watchlist for Consistent Profits - Newser
Applying Elliott Wave Theory to Armata Pharmaceuticals Inc.July 2025 Market Mood & Safe Entry Momentum Tips - Newser
Advanced analytics toolkit walkthrough for Armata Pharmaceuticals Inc.2025 Risk Factors & Technical Buy Zone Confirmations - Newser
Published on: 2025-08-19 17:03:43 - Newser
What technical models suggest about Armata Pharmaceuticals Inc.’s comebackPortfolio Gains Report & Consistent Income Trade Ideas - Newser
Can machine learning forecast Armata Pharmaceuticals Inc. recovery2025 Performance Recap & Real-Time Buy Signal Notifications - Newser
Will Armata Pharmaceuticals Inc. stock benefit from interest rate changesTrade Risk Assessment & Free High Return Stock Watch Alerts - Newser
Tools to assess Armata Pharmaceuticals Inc.’s risk profileProfit Target & Stepwise Entry/Exit Trade Alerts - Newser
Armata Pharmaceuticals Inc Stock (ARMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):